Funded Tech Companies

Spotlight Therapeutics

Wondering who provided funding to Spotlight Therapeutics? GV, GordonMD Global Investments and Epiq Capital joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Despite the promise of permanence, the full therapeutic potential of CRISPR gene editing is hindered by current delivery methods. To address the multiple limitations of cell, viral- and nanoparticle-mediated delivery for gene editing, we are developing a new class of biologics called Targeted Active Gene Editors (TAGE).

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/24/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mary Haak-Frendscho

        

Vice President

Mary Janatpour

        

Vice President

Hari Jayaram

        

Company Investors

• GV
• GordonMD Global Investments (Craig Gordon)
• Epiq Capital
• Magnetic Ventures
• Emerson Collective

Browse more funded tech companies:

Spotlight Medical | Spotlight Ticket Management

Share this article

About Our VC Transaction Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary